Plasmonic nanoparticle sensors: current progress, challenges, and future prospects
Bennett University · Universidade de Vigo · +24 more institutions
Abstract
Plasmonic nanoparticles (NPs) have played a significant role in the evolution of modern nanoscience and nanotechnology in terms of colloidal synthesis, general understanding of nanocrystal growth mechanisms, and their impact in a wide range of applications. They exhibit strong visible colors due to localized surface plasmon resonance (LSPR) that depends on their size, shape, composition, and the surrounding dielectric environment. Under resonant excitation, the LSPR of plasmonic NPs leads to a strong field enhancement near their surfaces and thus enhances various light-matter interactions. These unique optical properties of plasmonic NPs have been used to design chemical and biological sensors. Over the last…
Citation impact
- FWCI
- 12.96
- Percentile
- 100%
- References
- 828
Authors
46Topics & keywords
- Plasmon
- Nanotechnology
- Current (fluid)
- Emerging technologies
- Plasmonic nanoparticles
- Computer science
- Nanoparticle
- Data science
Funding
- NSNational Science FoundationAwards: 2224610, CBET-2224610, CBET-2316285, 1648451, MICIU/AEI/10.13039/501100011033, 2316285
- GOGovernment of the United Kingdom
- URUK Research and InnovationAward: 10063360
- CDCentres de Recerca de CatalunyaAwards: 501100011033, MCIN/AEI/10.13039/501100011033
- ICInstitut Català de Nanociència i NanotecnologiaAward: CEX2021-001214-S
- ECEuropean CommissionAwards: 101099066, 2021PFR-URV-B2-02, 2020SGR00166, H2020-MSCA-RISE, 10.13039/501100011033, MCIN/ AEI/10.13039/501100011033, 13039/501100011033, 501100011033, H2020, 883390, 823895, MICIU/AEI/10.13039/501100011033, 965018, 894227, AEI/10.13039/501100011033, H2020-MSCA-RISE-2018, H2020-MSCA, MCIN/AEI/10.13039/501100011033
- NRNational Research FoundationAward: 121787
- DRDefence Research and Development OrganisationAward: #ERIP/ER/1501138/M/01/319/D(R&D)
- GDGeneralitat de CatalunyaAwards: 10.13039/501100011033, 501100011033, MCIN/AEI/10.13039/501100011033, MICIU/AEI/10.13039/501100011033, MCIN/ AEI/10.13039/501100011033, CEX2021-001214-S, 2021 SGR 01464, PID2019, 2020SGR00166
- EJEusko JaurlaritzaAwards: MCIN/AEI/10.13039/501100011033, MICIU/AEI/10.13039/501100011033
- NRNational Research Foundation of KoreaAwards: RS-2024-00352256, 2020R1A5A1018052
- MOMinistry of Education, IndiaAward: F11/9/2019-U3(A)
- MDMinisterio de Ciencia e InnovaciónAwards: MCIN/AEI/10.13039/501100011033, PID2022-138724NB-I00
- URUniversitat Rovira i VirgiliAward: 2021PFR-URV-B2-02
- UOUniversity of HyderabadAward: UOH/IOE/RC1/RC1-20-016
- XDXunta de GaliciaAwards: ED431F2021/05, MICIU/AEI/10.13039/501100011033, MCIN/AEI/10.13039/501100011033
- NINational Institutes of HealthAwards: MCIN/AEI/10.13039/501100011033, R01EB029756-01A1, W81XWH, MICIU/AEI/10.13039/501100011033, H2020, R21AI178217
- H2Horizon 2020 Framework ProgrammeAwards: H2020-MSCA, H2020-MSCA-RISE, 894227, MCIN/AEI/10.13039/501100011033, PID2019, 965018-BIOCELLPHE, 883390, MICIU/AEI/10.13039/501100011033, 823895
- HEHORIZON EUROPE Framework ProgrammeAward: MCIN/AEI/10.13039/501100011033
- ACAdvanced Centre of Research in High Energy Materials, University of Hyderabad
- EREuropean Regional Development FundAwards: MCIN/AEI/10, PID2022-138724NB-I00, MICIU/AEI/10.13039/501100011033, H2020, MCIN/AEI/10.13039/501100011033, 10.13039/501100011033, 13039/501100011033, MCIN/ AEI/10.13039/501100011033, AEI/10.13039/501100011033, 501100011033, MICIU/AEI/10, PID2021-124795NB-I00, 823895
- AEAgencia Estatal de InvestigaciónAwards: AEI/10.13039/501100011033, 501100011033, CEX2021-001214-S, 10.13039/501100011033, MCIN/ AEI/10.13039/501100011033, MCIN/AEI/10.13039/501100011033, 13039, TED2021-131628A-I00, MICIU/AEI/10.13039/501100011033, 10.13039, PID2020-120306RB-I00, PDC2021-121787-I00, CNS2022-135531, PID2021-124795NB-I00, H2020, AEI/10, 13039/501100011033, AEI/10., PID2020-117371RA-I00, PID2019
- DODivision of Chemical, Bioengineering, Environmental, and Transport SystemsAwards: 1648451, CBET-2224610
- CDCongressionally Directed Medical Research ProgramsAward: W81XWH-20-1-0620
- HEHORIZON EUROPE Marie Sklodowska-Curie ActionsAward: 894227
- HEHORIZON EUROPE European Innovation CouncilAwards: MCIN/AEI/10.13039/501100011033, 101099066, 965018-BIOCELLPHE, HORIZON-EIC-2022-PATHFINDEROPEN-01